147 related articles for article (PubMed ID: 30298719)
1. Tumor Targeting and Lipid Rafts Disrupting Hyaluronic Acid-Cyclodextrin-Based Nanoassembled Structure for Cancer Therapy.
Lee SY; Ko SH; Shim JS; Kim DD; Cho HJ
ACS Appl Mater Interfaces; 2018 Oct; 10(43):36628-36640. PubMed ID: 30298719
[TBL] [Abstract][Full Text] [Related]
2. Boronic acid-tethered amphiphilic hyaluronic acid derivative-based nanoassemblies for tumor targeting and penetration.
Jeong JY; Hong EH; Lee SY; Lee JY; Song JH; Ko SH; Shim JS; Choe S; Kim DD; Ko HJ; Cho HJ
Acta Biomater; 2017 Apr; 53():414-426. PubMed ID: 28216300
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid/doxorubicin nanoassembly-releasing microspheres for the transarterial chemoembolization of a liver tumor.
Lee SY; Choi JW; Lee JY; Kim DD; Kim HC; Cho HJ
Drug Deliv; 2018 Nov; 25(1):1472-1483. PubMed ID: 29909706
[TBL] [Abstract][Full Text] [Related]
4. Mussel-Inspired Hyaluronic Acid Derivative Nanostructures for Improved Tumor Targeting and Penetration.
Lee SY; Park JH; Ko SH; Shim JS; Kim DD; Cho HJ
ACS Appl Mater Interfaces; 2017 Jul; 9(27):22308-22320. PubMed ID: 28621523
[TBL] [Abstract][Full Text] [Related]
5. Interconnected hyaluronic acid derivative-based nanoparticles for anticancer drug delivery.
Park JH; Cho HJ; Termsarasab U; Lee JY; Ko SH; Shim JS; Yoon IS; Kim DD
Colloids Surf B Biointerfaces; 2014 Sep; 121():380-7. PubMed ID: 24993066
[TBL] [Abstract][Full Text] [Related]
6. Dual CD44 and folate receptor-targeted nanoparticles for cancer diagnosis and anticancer drug delivery.
Lee JY; Termsarasab U; Park JH; Lee SY; Ko SH; Shim JS; Chung SJ; Cho HJ; Kim DD
J Control Release; 2016 Aug; 236():38-46. PubMed ID: 27320169
[TBL] [Abstract][Full Text] [Related]
7. Development of poly(lactic-co-glycolic) acid nanoparticles-embedded hyaluronic acid-ceramide-based nanostructure for tumor-targeted drug delivery.
Park JH; Lee JY; Termsarasab U; Yoon IS; Ko SH; Shim JS; Cho HJ; Kim DD
Int J Pharm; 2014 Oct; 473(1-2):426-33. PubMed ID: 25079433
[TBL] [Abstract][Full Text] [Related]
8. Polyethylene glycol-conjugated hyaluronic acid-ceramide self-assembled nanoparticles for targeted delivery of doxorubicin.
Cho HJ; Yoon IS; Yoon HY; Koo H; Jin YJ; Ko SH; Shim JS; Kim K; Kwon IC; Kim DD
Biomaterials; 2012 Feb; 33(4):1190-200. PubMed ID: 22074664
[TBL] [Abstract][Full Text] [Related]
9. A supramolecular nanoparticle system based on β-cyclodextrin-conjugated poly-l-lysine and hyaluronic acid for co-delivery of gene and chemotherapy agent targeting hepatocellular carcinoma.
Xiong Q; Cui M; Bai Y; Liu Y; Liu D; Song T
Colloids Surf B Biointerfaces; 2017 Jul; 155():93-103. PubMed ID: 28411478
[TBL] [Abstract][Full Text] [Related]
10. Supramolecular Complex of Methyl-β-cyclodextrin with Adamantane-Grafted Hyaluronic Acid as a Novel Antitumor Agent.
Elamin KM; Yamashita Y; Higashi T; Motoyama K; Arima H
Chem Pharm Bull (Tokyo); 2018 Mar; 66(3):277-285. PubMed ID: 29269686
[TBL] [Abstract][Full Text] [Related]
11. Effects of methyl-beta-cyclodextrin on T lymphocytes lipid rafts with aging.
Larbi A; Douziech N; Khalil A; Dupuis G; Gheraïri S; Guérard KP; Fülöp T
Exp Gerontol; 2004 Apr; 39(4):551-8. PubMed ID: 15050290
[TBL] [Abstract][Full Text] [Related]
12. Hyaluronic acid-ceramide-based optical/MR dual imaging nanoprobe for cancer diagnosis.
Cho HJ; Yoon HY; Koo H; Ko SH; Shim JS; Cho JH; Park JH; Kim K; Kwon IC; Kim DD
J Control Release; 2012 Aug; 162(1):111-8. PubMed ID: 22709587
[TBL] [Abstract][Full Text] [Related]
13. Selective delivery of PLXDC1 small interfering RNA to endothelial cells for anti-angiogenesis tumor therapy using CD44-targeted chitosan nanoparticles for epithelial ovarian cancer.
Kim GH; Won JE; Byeon Y; Kim MG; Wi TI; Lee JM; Park YY; Lee JW; Kang TH; Jung ID; Shin BC; Ahn HJ; Lee YJ; Sood AK; Han HD; Park YM
Drug Deliv; 2018 Nov; 25(1):1394-1402. PubMed ID: 29890852
[TBL] [Abstract][Full Text] [Related]
14. Disruption of lipid rafts causes apoptotic cell death in HaCaT keratinocytes.
Bang B; Gniadecki R; Gajkowska B
Exp Dermatol; 2005 Apr; 14(4):266-72. PubMed ID: 15810884
[TBL] [Abstract][Full Text] [Related]
15. Electrosprayed nanocomposites based on hyaluronic acid derivative and Soluplus for tumor-targeted drug delivery.
Lee SY; Lee JJ; Park JH; Lee JY; Ko SH; Shim JS; Lee J; Heo MY; Kim DD; Cho HJ
Colloids Surf B Biointerfaces; 2016 Sep; 145():267-274. PubMed ID: 27208440
[TBL] [Abstract][Full Text] [Related]
16. Effects of cholesterol depletion by cyclodextrin on the sphingolipid microdomains of the plasma membrane.
Ilangumaran S; Hoessli DC
Biochem J; 1998 Oct; 335 ( Pt 2)(Pt 2):433-40. PubMed ID: 9761744
[TBL] [Abstract][Full Text] [Related]
17. Esterase-sensitive cleavable histone deacetylase inhibitor-coupled hyaluronic acid nanoparticles for boosting anticancer activities against lung adenocarcinoma.
Lee SY; Hong EH; Jeong JY; Cho J; Seo JH; Ko HJ; Cho HJ
Biomater Sci; 2019 Nov; 7(11):4624-4635. PubMed ID: 31451819
[TBL] [Abstract][Full Text] [Related]
18. An α-tocopheryl succinate enzyme-based nanoassembly for cancer imaging and therapy.
Lee SY; Cho HJ
Drug Deliv; 2018 Nov; 25(1):738-749. PubMed ID: 29516756
[TBL] [Abstract][Full Text] [Related]
19. Involvement of cholesterol depletion from lipid rafts in apoptosis induced by methyl-β-cyclodextrin.
Onodera R; Motoyama K; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
Int J Pharm; 2013 Aug; 452(1-2):116-23. PubMed ID: 23684659
[TBL] [Abstract][Full Text] [Related]
20. Iodinated hyaluronic acid oligomer-based nanoassemblies for tumor-targeted drug delivery and cancer imaging.
Lee JY; Chung SJ; Cho HJ; Kim DD
Biomaterials; 2016 Apr; 85():218-31. PubMed ID: 26874284
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
